Cytokinetics, Inc. (CYTK)

74.34 -2.57 (-3.34%) USD  |  NASDAQ  |  May 11, 15:11
More

Cytokinetics Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for CYTK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Bristol Myers Squibb Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade
Revolution Medicines, Inc. Upgrade